Search
The research arm of Memorial Sloan Kettering was established to apply industrial techniques to the study of cancer.
Memorial Sloan Kettering’s Bob Li served as principal investigator of the CodeBreaK 100 trial, the largest clinical trial conducted to date exclusively for patients with the KRAS G12C mutation.
MSK researchers are helping to map the landscape of viruses that infect us all, and to analyze the impact they have on human health and disease.
Spend a day with the expert team in MSK's world-renowned sarcoma service.
Michelle Smith-Levitin was facing the devastating possibility of having her leg amputated when she sought a second opinion at MSK.
In a recent study, Memorial Sloan Kettering scientists used stem-cell engineering to repair brain injuries in rats. The results raise hope for future therapies that could prevent or fix nerve damage in cancer patients who need brain radiation.
Learn about the aspiring scientists who were celebrated this month for completing a unique summer research program.
MSK’s sarcoma team is dedicated to developing new approaches for treating people with this rare cancer.
MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.
Scientists are dusting off their biochemistry textbooks in the hunt for clues to cancer.